phase 2 patient studies

Phase 1b and 2a – trials in patients 

We liaise with physicians in London hospitals, and with patient support groups and pharmacies, to recruit patients for proof-of-concept trials. Sometimes we work with local GPs or GP consortiums, and with a company that can access GP patient records in compliance with GDPR.

Taking advantage of our extensive experience, we devise a bespoke recruitment strategy to target the required population.  We have a staff of skilled, specialised nurses for specific disease areas.  We allocate patient liaison officers to ensure that we meet the needs of specific patients and provide them with appropriate specialist care.

We assess realistically the feasibility of each trial design and the likely rate of patient recruitment, and advise on strategies to accelerate recruitment.

Working with the NHS

We liaise with local hospitals, such as Central Middlesex, Northwick Park, and Hammersmith, to set up patient identification centres (PICs).

For each trial that involves patient cohorts, our specialist Patient Trial Coordinator creates a bespoke recruitment plan to identify suitable subjects.

Patient facilities and accommodation

We have designated ward bays and a private room to accommodate patients, and we offer specialised menus as required.

Our Respiratory Nurse Specialist and Clinical Nurse Specialist review the necessary facilities and procedures for our patient trials, and give support and training to ward staff.

Our record of achievement

We have panels of patients with conditions including asthma, COPD, osteoarthritis and obesity.

Since 1993, we’ve done proof-of-concept trials in many different conditions.  We’ve successfully recruited patients into early-phase clinical trials of IMP for a wide range of indications

  • acne scars
  • alcohol dependence
  • allergic rhinitis
  • Alzheimer’s
  • amyloidosis
  • asthma
  • atopic dermatitis
  • benign prostatic hypertrophy
  • cardiac amyloidosis
  • chronic obstructive pulmonary disease (COPD)
  • coeliac disease
  • contraception via patch
  • coronary artery disease
  • Crohn’s disease
  • depression
  • diabetes type 2
  • Down syndrome
  • elevated lipoprotein(a)
  • erectile dysfunction
  • gastro-oesophageal reflux disease (GERD/GORD)
  • genital herpes
  • H pylori infection
  • haemosiderosis
  • heart failure
  • hepatitis B
  • hormone replacement therapy
  • hyperhidrosis
  • idiopathic pulmonary fibrosis (IPF)
  • major depressive disorder (MDD)
  • migraine
  • obesity
  • osteoarthritis
  • Parkinson’s
  • premenstrual syndrome
  • psoriasis
  • pulmonary arterial hypertension (PAH)
  • schizophrenia
  • seasonal allergic rhinitis (SAR)
  • stretch marks (striae distensae alba)
  • subjective cognitive decline (SCD)
  • systemic lupus erythematosus (SLE)
  • thalassaemia